FDA Inspection 1166561 — Covenant Medical Center
The FDA completed an inspection of Covenant Medical Center on April 8, 2022 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 8, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lubbock, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3618 | 21 CFR 606.100(b)(19) | Procedure for HIV or HCV lookback |
| 61 | 21 CFR 606.60(a) | Provide proper equipment to meet requirements |